Epigenetics company Base Genomics launches, based on a new invention to sequence DNA methylation developed at the Ludwig Institute for Cancer Research Branch at the University of Oxford The technology, TAPS (TET...read more
Category - Liquid biopsy
MENLO PARK, Calif., May 6, 2020 – GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced a $390 million Series D financing round. New investors including Public...read more
2019 in Review – Major Acquisitions, Population Studies, Gigantic Founding Rounds, Technological Advancements, and ….
The year 2019 comes to an end with significant advancements in precision medicine, genetics, genomics, CRISPR technology, liquid biopsy, and immunotherapy. Highlights and notable news included various technological...read more